Edmond de Rothschild co-leads EUR15m series A financing of Allecra Therapeutics
Edmond de Rothschild Investment Partners’ BioDiscovery 4 – its fourth fund dedicated to life sciences – has made its first investment through its participation in the series A financing round of Allecra Therapeutics, which it co-leads with Forbion Capital Partners. EMBL Ventures is also part of the syndicate.



